Table of contents

Original Articles

• High dose rate (HDR) cervical ring applicator to control bleeding from cervical carcinoma (1 January, 2002)

  P. W Grigsby, L Portelance, J. F Williamson
• Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II, and III cervical cancer (1 January, 2002)

  I Vergote, F Amant, P Berteloot, M Van Gramberen
• High-dose-rate brachytherapy for vaginal cancer: Learning from treatment complications (1 January, 2002)

  W. C Tyree, H Cardenes, M Randall, L Papiez
• The prognostic value of histopathologic grading parameters and microvessel density in patients with early squamous cell carcinoma of the uterine cervix. (1 January, 2002)

  M Graflund, B Sorbe, A Hussein, M Bryne, M Karlsson
• Clinicopathological study of the pattern and significance of cervical involvement in cases of endometrial adenocarcinoma (1 January, 2002)

  L. B Jordan, A Al-Nafussi
• Significance of morphometric, DNA cytometric features, and other prognostic markers on survival of endometrial cancer patients in northern Norway (1 January, 2002)

  A Ørbo, M Rydningen, B Straume, S Lysne
• Laparoscopically assisted vaginal hysterectomy versus abdominal hysterectomy in stage I endometrial cancer (1 January, 2002)

  K. M Fram
• Immunohistochemical localization of metallothionein in benign and malignant epithelial ovarian tumors (1 January, 2002)

  W. G Mccluggage, K Strand, A Abdulkadir
• Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancer (1 January, 2002)

  A Hasenburg, D. C Fischer, X.-W Tong, A Rojas-Martinez, C Nyberg-Hoffman, M Orlowska-Volk, P Kohlberger, R. H Kaufman, I Ramzy, E Aguilar-Cordova, D. G Kieback
• Immunohistochemical study of p185 HER2 and DF3 in primary breast cancer and correlation with CA-15-3 serum tumor marker (1 January, 2002)

  C Dimas, M Frangos-Plemenos, E Kouskouni, A Kondis-Pafitis
• The experimental study of ovarian carcinoma vaccine modified by human B7-1 and IFN-γ genes (1 January, 2002)

  H.-N Qian, G.-Z Liu, S.-J Cao, J Feng, X Ye
• Use of CA-125 and ultrasound in high-risk women (1 January, 2002)

  S Laframboise, R Nedelcu, J Murphy, D. E. C Cole, B Rosen
• Characterization of mast cells according to their content of tryptase and chymase in normal and neoplastic human uterine cervix (1 January, 2002)

  A Cabanillas-Saez, J. A Schalper, S. M Nicovani, M. I Rudolph
• Sequence variations of the late upstream region of HPV16 in cervical intraepithelial neoplasm and invasive carcinoma (1 January, 2002)

  T Pang, X Hu, J Ponten
• Laminin-5 γ 2 chain as an invasivity marker for uni- and multifocal lesions in the lower anogenital tract (1 January, 2002)

  B Nordström, N Einhorn, C Silfverswärd, K Sjövall, K Tryggvason, G Auer
• Nuclear DNA content, proliferative activity, and p53 expression related to clinical and histopathologic features in endometrial carcinoma (1 January, 2002)

  C Lundgren, G Auer, B Frankendal, B Moberger, B Nilsson, B Nordström
• Postoperative chemotherapy in advanced ovarian granulosa cell tumors (1 January, 2002)

  I. A Al-Badawi, P. M. A Brasher, P Ghatage, J. G Nation, A Schepansky, G. C. E Stuart